Carl Zeiss Meditec AG is a leading medical technology company specializing in innovative products and solutions for ophthalmology and microsurgery. Headquartered in Jena, Germany, and founded in 1846,... Carl Zeiss Meditec AG is a leading medical technology company specializing in innovative products and solutions for ophthalmology and microsurgery. Headquartered in Jena, Germany, and founded in 1846, it operates as a subsidiary of the ZEISS Group, leveraging a global distribution network across Europe, North America, and Asia. The company divides its activities into two key segments: Ophthalmology, which provides diagnostic and therapeutic tools for eye conditions like ametropia, cataracts, glaucoma, and retinal disorders, including slit lamps, optical coherence tomography devices, surgical microscopes, phacoemulsification systems, vitrectomy equipment, and intraocular lenses; and Microsurgery, offering visualization solutions for minimally invasive procedures in neurosurgery, ear-nose-throat, spine, plastic and reconstructive surgery, and dentistry. Carl Zeiss Meditec AG serves physicians, ophthalmology clinics, hospitals, and private practices worldwide, driving advancements in healthcare through cutting-edge technologies, digital workflow solutions, and AI-integrated applications that enhance clinical efficiency and patient outcomes. With over 50% of its workforce in key markets like the USA, Japan, Spain, and France, it plays a pivotal role in the medical device sector, focusing on precision optics and comprehensive portfolios for vision preservation and surgical precision.
No Climate Targets data disclosed by Carl Zeiss Meditec
We reviewed Carl Zeiss Meditec's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.
If you would like us to review newly published materials or reassess the most recent
disclosures, you can submit a data update request.